Erlotib 150mg Tablet: Erlotib 150Mg Tablet is prescribed to patients suffering from metastatic lung cancer, or cancer of the lung which is at a very advanced stage. It is also used in the treatment of some kinds of pancreatic cancers, along with a combination of other drugs. Erlotib 150Mg Tablet is known to be a tyrosine kinase inhibitor, and functions by preventing growth of cancer cells, and destroying them in the process. Erlotib 150Mg Tablet is generally not prescribed to patients who are hypersensitive to any substance that is present in it, or are undergoing chemotherapy that is platinum based. Patients who are using a proton pump inhibitor should not take Erlotib 150Mg Tablet either. The medicine should be taken orally at least an hour before a meal. You can gulp it down with the help of some water. In case of a missed dose, get in touch with your health professional and seek advice. Common Side Effects of Erlotib 150mg Tablet: In addition to its intended effect,